465 related articles for article (PubMed ID: 6432902)
21. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
Cordier G; Samarut C; Revillard JP
Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
[TBL] [Abstract][Full Text] [Related]
23. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
[TBL] [Abstract][Full Text] [Related]
24. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
25. Natural and antibody-dependent killer cells in the thymus.
Zöller M; Andrighetto G; Heyman B
Eur J Immunol; 1982 Nov; 12(11):914-21. PubMed ID: 6185347
[TBL] [Abstract][Full Text] [Related]
26. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
[TBL] [Abstract][Full Text] [Related]
27. Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
Ramos OF; Masucci MG; Klein E
Cell Immunol; 1985 Mar; 91(1):178-92. PubMed ID: 3871663
[TBL] [Abstract][Full Text] [Related]
28. A distinct lymphocyte subset displaying spontaneous cytotoxic activity against chicken erythrocytes. Morphological, cytochemical, immunocytochemical and functional characterization.
Magyarlaki T; Szekeres J; Matolcsy A
Acta Morphol Hung; 1991; 39(1):21-32. PubMed ID: 1684691
[TBL] [Abstract][Full Text] [Related]
29. Phorbol-ester stimulated lysis of weak and nonspecific target cells by cytotoxic T lymphocytes.
Russell JH
J Immunol; 1986 Jan; 136(1):23-7. PubMed ID: 2415619
[TBL] [Abstract][Full Text] [Related]
30. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
32. A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A.
O'Shea JJ; McVicar DW; Kuhns DB; Ortaldo JR
J Immunol; 1992 Apr; 148(8):2497-502. PubMed ID: 1532816
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human K cells by surface antigens and morphology at the single cell level.
Wåhlin B; Perlmann P
J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
[TBL] [Abstract][Full Text] [Related]
35. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.
Perussia B; Trinchieri G; Jackson A; Warner NL; Faust J; Rumpold H; Kraft D; Lanier LL
J Immunol; 1984 Jul; 133(1):180-9. PubMed ID: 6233371
[TBL] [Abstract][Full Text] [Related]
36. Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.
Ullberg M; Jondal M
Clin Exp Immunol; 1983 Jul; 53(1):101-8. PubMed ID: 6872324
[TBL] [Abstract][Full Text] [Related]
37. Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity.
Dillman RO; Johnson DE; Shawler DL
J Immunol; 1986 Jan; 136(2):728-31. PubMed ID: 3079792
[TBL] [Abstract][Full Text] [Related]
38. Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.
Lang NP; Ortaldo JR; Bonnard GD; Herberman RB
J Natl Cancer Inst; 1982 Aug; 69(2):339-43. PubMed ID: 6180205
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
Fuson EW; Cole AJ; Hubbard RA
J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
Santoli D; Trinchieri G; Koprowski H
J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
